Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis

NCT02274792 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
132
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen